Head-to-head comparison of sirolimus- versus paclitaxel-coated balloon angioplasty in the femoropopliteal artery: study protocol for the randomized controlled SIRONA trial View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2021-09-28

AUTHORS

Ulf Teichgräber, Maja Ingwersen, Stephanie Platzer, Thomas Lehmann, Thomas Zeller, René Aschenbach, Dierk Scheinert

ABSTRACT

BackgroundEndovascular revascularization has established as the first-line therapy of femoropopliteal artery disease. Paclitaxel-coated balloon angioplasty proved to be superior to plain old balloon angioplasty (POBA) regarding prevention of restenosis and need for recurrent revascularization. Over the past years, paclitaxel was the only active drug to inhibit neointimal proliferation which could be processed to an appropriate balloon coating. The purpose of this study is to assess whether efficacy and safety of sirolimus-coated balloon angioplasty is noninferior to paclitaxel-coated balloon angioplasty.MethodsThis randomized controlled, single-blinded, multicentre, investigator-initiated noninferiority trial aims to enrol a total of 478 participants with symptomatic femoropopliteal artery disease of Rutherford category 2 to 4 due to de novo stenosis or restenosis. After pre-dilation, participants will be allocated in a 1:1 ratio to either sirolimus- or paclitaxel-coated balloon angioplasty. Post-dilation with the drug-coated balloon (DCB) used or standard balloon is mandatory in case ≥ 50%, and optional in case of ≥ 30% residual diameter stenosis. Bailout stenting with bare-metal nitinol stents should be conducted in case of flow-limiting dissection. Primary noninferiority endpoints are primary patency and the composite of all-cause mortality, major target limb amputation, and clinically driven target lesion revascularization at 12 months. Secondary outcomes are clinical and hemodynamic improvement, change in health-related quality of life, and safety throughout 60 months.DiscussionAlthough concerns about long-term safety of paclitaxel-coated devices were not confirmed by recent patient-level data analyses, conflicting evidence contributed to a loss of confidence among patients and physicians. Therefore, sirolimus, known for a broader therapeutic range than paclitaxel, may serve as a welcome alternative. This will be justified if noninferiority of sirolimus-coated balloon angioplasty against the current standard of paclitaxel-coated balloon angioplasty can be demonstrated.Trial registrationClinicalTrials.govNCT04475783. Registered on 17 July 2020EUDAMED No. CIV-20-11-035172, DRKS00022452 More... »

PAGES

665

Identifiers

URI

http://scigraph.springernature.com/pub.10.1186/s13063-021-05631-9

DOI

http://dx.doi.org/10.1186/s13063-021-05631-9

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1141460066

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/34583746


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1102", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Cardiorespiratory Medicine and Haematology", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Angioplasty, Balloon", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Coated Materials, Biocompatible", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Femoral Artery", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Multicenter Studies as Topic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Paclitaxel", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Peripheral Arterial Disease", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Popliteal Artery", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Quality of Life", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Randomized Controlled Trials as Topic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Sirolimus", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Treatment Outcome", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Vascular Patency", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Radiology, Jena University Hospital, Friedrich-Schiller-University Jena, Jena, Germany", 
          "id": "http://www.grid.ac/institutes/grid.275559.9", 
          "name": [
            "Department of Radiology, Jena University Hospital, Friedrich-Schiller-University Jena, Jena, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Teichgr\u00e4ber", 
        "givenName": "Ulf", 
        "id": "sg:person.0601002133.56", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0601002133.56"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Radiology, Jena University Hospital, Friedrich-Schiller-University Jena, Jena, Germany", 
          "id": "http://www.grid.ac/institutes/grid.275559.9", 
          "name": [
            "Department of Radiology, Jena University Hospital, Friedrich-Schiller-University Jena, Jena, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ingwersen", 
        "givenName": "Maja", 
        "id": "sg:person.01067067131.20", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01067067131.20"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Center for Clinical Studies, Jena University Hospital, Friedrich-Schiller-University Jena, Jena, Germany", 
          "id": "http://www.grid.ac/institutes/grid.275559.9", 
          "name": [
            "Center for Clinical Studies, Jena University Hospital, Friedrich-Schiller-University Jena, Jena, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Platzer", 
        "givenName": "Stephanie", 
        "id": "sg:person.012273723215.03", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012273723215.03"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Center for Clinical Studies, Jena University Hospital, Friedrich-Schiller-University Jena, Jena, Germany", 
          "id": "http://www.grid.ac/institutes/grid.275559.9", 
          "name": [
            "Center for Clinical Studies, Jena University Hospital, Friedrich-Schiller-University Jena, Jena, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lehmann", 
        "givenName": "Thomas", 
        "id": "sg:person.01121532415.50", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01121532415.50"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Angiology, Universit\u00e4ts-Herzzentrum Freiburg-Bad Krozingen, Bad Krozingen, Germany", 
          "id": "http://www.grid.ac/institutes/grid.418466.9", 
          "name": [
            "Department of Angiology, Universit\u00e4ts-Herzzentrum Freiburg-Bad Krozingen, Bad Krozingen, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Zeller", 
        "givenName": "Thomas", 
        "id": "sg:person.01306206724.74", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01306206724.74"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Radiology, Jena University Hospital, Friedrich-Schiller-University Jena, Jena, Germany", 
          "id": "http://www.grid.ac/institutes/grid.275559.9", 
          "name": [
            "Department of Radiology, Jena University Hospital, Friedrich-Schiller-University Jena, Jena, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Aschenbach", 
        "givenName": "Ren\u00e9", 
        "id": "sg:person.0736200777.98", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0736200777.98"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Angiology, University Hospital Leipzig, Leipzig, Germany", 
          "id": "http://www.grid.ac/institutes/grid.411339.d", 
          "name": [
            "Department of Angiology, University Hospital Leipzig, Leipzig, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Scheinert", 
        "givenName": "Dierk", 
        "id": "sg:person.01230314120.98", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01230314120.98"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/s00270-019-02194-w", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1112585900", 
          "https://doi.org/10.1007/s00270-019-02194-w"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2021-09-28", 
    "datePublishedReg": "2021-09-28", 
    "description": "BackgroundEndovascular revascularization has established as the first-line therapy of femoropopliteal artery disease. Paclitaxel-coated balloon angioplasty proved to be superior to plain old balloon angioplasty (POBA) regarding prevention of restenosis and need for recurrent revascularization. Over the past years, paclitaxel was the only active drug to inhibit neointimal proliferation which could be processed to an appropriate balloon coating. The purpose of this study is to assess whether efficacy and safety of sirolimus-coated balloon angioplasty is noninferior to paclitaxel-coated balloon angioplasty.MethodsThis randomized controlled, single-blinded, multicentre, investigator-initiated noninferiority trial aims to enrol a total of 478 participants with symptomatic femoropopliteal artery disease of Rutherford category 2 to 4 due to de novo stenosis or restenosis. After pre-dilation, participants will be allocated in a 1:1 ratio to either sirolimus- or paclitaxel-coated balloon angioplasty. Post-dilation with the drug-coated balloon (DCB) used or standard balloon is mandatory in case \u2265 50%, and optional in case of \u2265 30% residual diameter stenosis. Bailout stenting with bare-metal nitinol stents should be conducted in case of flow-limiting dissection. Primary noninferiority endpoints are primary patency and the composite of all-cause mortality, major target limb amputation, and clinically driven target lesion revascularization at 12 months. Secondary outcomes are clinical and hemodynamic improvement, change in health-related quality of life, and safety throughout 60 months.DiscussionAlthough concerns about long-term safety of paclitaxel-coated devices were not confirmed by recent patient-level data analyses, conflicting evidence contributed to a loss of confidence among patients and physicians. Therefore, sirolimus, known for a broader therapeutic range than paclitaxel, may serve as a welcome alternative. This will be justified if noninferiority of sirolimus-coated balloon angioplasty against the current standard of paclitaxel-coated balloon angioplasty can be demonstrated.Trial registrationClinicalTrials.govNCT04475783. Registered on 17 July 2020EUDAMED No. CIV-20-11-035172, DRKS00022452", 
    "genre": "article", 
    "id": "sg:pub.10.1186/s13063-021-05631-9", 
    "inLanguage": "en", 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1297400", 
        "issn": [
          "1468-6708", 
          "1745-6215"
        ], 
        "name": "Trials", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "22"
      }
    ], 
    "keywords": [
      "paclitaxel-coated balloon angioplasty", 
      "plain old balloon angioplasty", 
      "femoropopliteal artery disease", 
      "drug-coated balloons", 
      "balloon angioplasty", 
      "artery disease", 
      "major target limb amputation", 
      "only active drug", 
      "Rutherford category 2", 
      "de novo stenosis", 
      "bare metal nitinol stents", 
      "primary noninferiority endpoint", 
      "target limb amputation", 
      "target lesion revascularization", 
      "paclitaxel-coated devices", 
      "first-line therapy", 
      "residual diameter stenosis", 
      "flow-limiting dissection", 
      "health-related quality", 
      "patient-level data analysis", 
      "prevention of restenosis", 
      "long-term safety", 
      "broad therapeutic range", 
      "recurrent revascularization", 
      "novo stenosis", 
      "primary patency", 
      "cause mortality", 
      "lesion revascularization", 
      "hemodynamic improvement", 
      "Secondary outcomes", 
      "standard balloon", 
      "diameter stenosis", 
      "femoropopliteal arteries", 
      "therapeutic range", 
      "study protocol", 
      "neointimal proliferation", 
      "noninferiority trial", 
      "angioplasty", 
      "limb amputation", 
      "balloon coating", 
      "active drug", 
      "head comparison", 
      "revascularization", 
      "sirolimus", 
      "nitinol stents", 
      "category 2", 
      "stenosis", 
      "restenosis", 
      "current standard", 
      "disease", 
      "paclitaxel", 
      "trials", 
      "months", 
      "balloon", 
      "safety", 
      "past year", 
      "welcome alternative", 
      "participants", 
      "multicentre", 
      "MethodsThis", 
      "patency", 
      "patients", 
      "noninferiority", 
      "artery", 
      "loss of confidence", 
      "amputation", 
      "therapy", 
      "mortality", 
      "stents", 
      "physicians", 
      "dissection", 
      "cases", 
      "endpoint", 
      "prevention", 
      "drugs", 
      "efficacy", 
      "outcomes", 
      "total", 
      "proliferation", 
      "years", 
      "head", 
      "evidence", 
      "data analysis", 
      "study", 
      "life", 
      "protocol", 
      "loss", 
      "improvement", 
      "changes", 
      "need", 
      "purpose", 
      "concern", 
      "quality", 
      "ratio", 
      "confidence", 
      "alternative", 
      "standards", 
      "comparison", 
      "analysis", 
      "range", 
      "devices", 
      "bailout", 
      "composites", 
      "coatings"
    ], 
    "name": "Head-to-head comparison of sirolimus- versus paclitaxel-coated balloon angioplasty in the femoropopliteal artery: study protocol for the randomized controlled SIRONA trial", 
    "pagination": "665", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1141460066"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1186/s13063-021-05631-9"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "34583746"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1186/s13063-021-05631-9", 
      "https://app.dimensions.ai/details/publication/pub.1141460066"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-05-10T10:31", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220509/entities/gbq_results/article/article_904.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1186/s13063-021-05631-9"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/s13063-021-05631-9'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/s13063-021-05631-9'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/s13063-021-05631-9'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/s13063-021-05631-9'


 

This table displays all metadata directly associated to this object as RDF triples.

272 TRIPLES      22 PREDICATES      144 URIs      135 LITERALS      20 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1186/s13063-021-05631-9 schema:about N03b9b5f61437408f99029487059cf684
2 N171fa6d3582242a8bd42309382bca21e
3 N189932fce3e942579f133659c5115539
4 N2009eac362364480a535fcaf2f5c4ff8
5 N226a7b098ed3437e8e16500f5b0c6ff7
6 N2ab4f99c85c04b3998da4e148c3f2c1d
7 N4262dcb993954313a1da03736576b4d1
8 N559a6297fac24b159fc06ccb206d2b6f
9 N60770323c24b4192999f5cead1d58aea
10 N61d8cc2a83ee4f5f8dbcb88dda46e585
11 Naf8aa0bc3a36461397c83949b3346752
12 Nf3e752d0dab040cd9ea389e43b5c9718
13 Nf47e0533d32e4387a9631371414f9a60
14 anzsrc-for:11
15 anzsrc-for:1102
16 schema:author Nd1aaee0c452343d2be9d99d3d5b459cf
17 schema:citation sg:pub.10.1007/s00270-019-02194-w
18 schema:datePublished 2021-09-28
19 schema:datePublishedReg 2021-09-28
20 schema:description BackgroundEndovascular revascularization has established as the first-line therapy of femoropopliteal artery disease. Paclitaxel-coated balloon angioplasty proved to be superior to plain old balloon angioplasty (POBA) regarding prevention of restenosis and need for recurrent revascularization. Over the past years, paclitaxel was the only active drug to inhibit neointimal proliferation which could be processed to an appropriate balloon coating. The purpose of this study is to assess whether efficacy and safety of sirolimus-coated balloon angioplasty is noninferior to paclitaxel-coated balloon angioplasty.MethodsThis randomized controlled, single-blinded, multicentre, investigator-initiated noninferiority trial aims to enrol a total of 478 participants with symptomatic femoropopliteal artery disease of Rutherford category 2 to 4 due to de novo stenosis or restenosis. After pre-dilation, participants will be allocated in a 1:1 ratio to either sirolimus- or paclitaxel-coated balloon angioplasty. Post-dilation with the drug-coated balloon (DCB) used or standard balloon is mandatory in case ≥ 50%, and optional in case of ≥ 30% residual diameter stenosis. Bailout stenting with bare-metal nitinol stents should be conducted in case of flow-limiting dissection. Primary noninferiority endpoints are primary patency and the composite of all-cause mortality, major target limb amputation, and clinically driven target lesion revascularization at 12 months. Secondary outcomes are clinical and hemodynamic improvement, change in health-related quality of life, and safety throughout 60 months.DiscussionAlthough concerns about long-term safety of paclitaxel-coated devices were not confirmed by recent patient-level data analyses, conflicting evidence contributed to a loss of confidence among patients and physicians. Therefore, sirolimus, known for a broader therapeutic range than paclitaxel, may serve as a welcome alternative. This will be justified if noninferiority of sirolimus-coated balloon angioplasty against the current standard of paclitaxel-coated balloon angioplasty can be demonstrated.Trial registrationClinicalTrials.govNCT04475783. Registered on 17 July 2020EUDAMED No. CIV-20-11-035172, DRKS00022452
21 schema:genre article
22 schema:inLanguage en
23 schema:isAccessibleForFree true
24 schema:isPartOf N0f7bb8777e4e419d8f9d15b9d2ee67f7
25 Ne7fec6d5906046faa6d345ddf03c44e9
26 sg:journal.1297400
27 schema:keywords MethodsThis
28 Rutherford category 2
29 Secondary outcomes
30 active drug
31 alternative
32 amputation
33 analysis
34 angioplasty
35 artery
36 artery disease
37 bailout
38 balloon
39 balloon angioplasty
40 balloon coating
41 bare metal nitinol stents
42 broad therapeutic range
43 cases
44 category 2
45 cause mortality
46 changes
47 coatings
48 comparison
49 composites
50 concern
51 confidence
52 current standard
53 data analysis
54 de novo stenosis
55 devices
56 diameter stenosis
57 disease
58 dissection
59 drug-coated balloons
60 drugs
61 efficacy
62 endpoint
63 evidence
64 femoropopliteal arteries
65 femoropopliteal artery disease
66 first-line therapy
67 flow-limiting dissection
68 head
69 head comparison
70 health-related quality
71 hemodynamic improvement
72 improvement
73 lesion revascularization
74 life
75 limb amputation
76 long-term safety
77 loss
78 loss of confidence
79 major target limb amputation
80 months
81 mortality
82 multicentre
83 need
84 neointimal proliferation
85 nitinol stents
86 noninferiority
87 noninferiority trial
88 novo stenosis
89 only active drug
90 outcomes
91 paclitaxel
92 paclitaxel-coated balloon angioplasty
93 paclitaxel-coated devices
94 participants
95 past year
96 patency
97 patient-level data analysis
98 patients
99 physicians
100 plain old balloon angioplasty
101 prevention
102 prevention of restenosis
103 primary noninferiority endpoint
104 primary patency
105 proliferation
106 protocol
107 purpose
108 quality
109 range
110 ratio
111 recurrent revascularization
112 residual diameter stenosis
113 restenosis
114 revascularization
115 safety
116 sirolimus
117 standard balloon
118 standards
119 stenosis
120 stents
121 study
122 study protocol
123 target lesion revascularization
124 target limb amputation
125 therapeutic range
126 therapy
127 total
128 trials
129 welcome alternative
130 years
131 schema:name Head-to-head comparison of sirolimus- versus paclitaxel-coated balloon angioplasty in the femoropopliteal artery: study protocol for the randomized controlled SIRONA trial
132 schema:pagination 665
133 schema:productId N103b50b817cd483da3a79a7f8efeace2
134 N9a7e713c2d76411590e87e1199b743f9
135 Naf88c71e37ff4f8ebbeafa34347233fb
136 schema:sameAs https://app.dimensions.ai/details/publication/pub.1141460066
137 https://doi.org/10.1186/s13063-021-05631-9
138 schema:sdDatePublished 2022-05-10T10:31
139 schema:sdLicense https://scigraph.springernature.com/explorer/license/
140 schema:sdPublisher N2bfb574844974754a26fc0bb659eef9b
141 schema:url https://doi.org/10.1186/s13063-021-05631-9
142 sgo:license sg:explorer/license/
143 sgo:sdDataset articles
144 rdf:type schema:ScholarlyArticle
145 N03b9b5f61437408f99029487059cf684 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
146 schema:name Treatment Outcome
147 rdf:type schema:DefinedTerm
148 N0f7bb8777e4e419d8f9d15b9d2ee67f7 schema:issueNumber 1
149 rdf:type schema:PublicationIssue
150 N103b50b817cd483da3a79a7f8efeace2 schema:name pubmed_id
151 schema:value 34583746
152 rdf:type schema:PropertyValue
153 N12f03eb904704e61a8661ae8661c3423 rdf:first sg:person.0736200777.98
154 rdf:rest Na0dc6cde4a154b41929ada1016768b2a
155 N171fa6d3582242a8bd42309382bca21e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
156 schema:name Angioplasty, Balloon
157 rdf:type schema:DefinedTerm
158 N189932fce3e942579f133659c5115539 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
159 schema:name Paclitaxel
160 rdf:type schema:DefinedTerm
161 N2009eac362364480a535fcaf2f5c4ff8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
162 schema:name Multicenter Studies as Topic
163 rdf:type schema:DefinedTerm
164 N20631b7f7a1644508ce910f876aaeb99 rdf:first sg:person.012273723215.03
165 rdf:rest Naf2bab0ef9894f95854d0fbf493363f4
166 N226a7b098ed3437e8e16500f5b0c6ff7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
167 schema:name Coated Materials, Biocompatible
168 rdf:type schema:DefinedTerm
169 N2756ea63929142f09f2549df340eb59d rdf:first sg:person.01306206724.74
170 rdf:rest N12f03eb904704e61a8661ae8661c3423
171 N2ab4f99c85c04b3998da4e148c3f2c1d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
172 schema:name Sirolimus
173 rdf:type schema:DefinedTerm
174 N2bfb574844974754a26fc0bb659eef9b schema:name Springer Nature - SN SciGraph project
175 rdf:type schema:Organization
176 N4262dcb993954313a1da03736576b4d1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
177 schema:name Randomized Controlled Trials as Topic
178 rdf:type schema:DefinedTerm
179 N559a6297fac24b159fc06ccb206d2b6f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
180 schema:name Humans
181 rdf:type schema:DefinedTerm
182 N60770323c24b4192999f5cead1d58aea schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
183 schema:name Quality of Life
184 rdf:type schema:DefinedTerm
185 N61d8cc2a83ee4f5f8dbcb88dda46e585 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
186 schema:name Femoral Artery
187 rdf:type schema:DefinedTerm
188 N9a7e713c2d76411590e87e1199b743f9 schema:name doi
189 schema:value 10.1186/s13063-021-05631-9
190 rdf:type schema:PropertyValue
191 Na0dc6cde4a154b41929ada1016768b2a rdf:first sg:person.01230314120.98
192 rdf:rest rdf:nil
193 Naf2bab0ef9894f95854d0fbf493363f4 rdf:first sg:person.01121532415.50
194 rdf:rest N2756ea63929142f09f2549df340eb59d
195 Naf88c71e37ff4f8ebbeafa34347233fb schema:name dimensions_id
196 schema:value pub.1141460066
197 rdf:type schema:PropertyValue
198 Naf8aa0bc3a36461397c83949b3346752 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
199 schema:name Popliteal Artery
200 rdf:type schema:DefinedTerm
201 Nba7665b5d2414ef0b326b3614e0b7d6d rdf:first sg:person.01067067131.20
202 rdf:rest N20631b7f7a1644508ce910f876aaeb99
203 Nd1aaee0c452343d2be9d99d3d5b459cf rdf:first sg:person.0601002133.56
204 rdf:rest Nba7665b5d2414ef0b326b3614e0b7d6d
205 Ne7fec6d5906046faa6d345ddf03c44e9 schema:volumeNumber 22
206 rdf:type schema:PublicationVolume
207 Nf3e752d0dab040cd9ea389e43b5c9718 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
208 schema:name Vascular Patency
209 rdf:type schema:DefinedTerm
210 Nf47e0533d32e4387a9631371414f9a60 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
211 schema:name Peripheral Arterial Disease
212 rdf:type schema:DefinedTerm
213 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
214 schema:name Medical and Health Sciences
215 rdf:type schema:DefinedTerm
216 anzsrc-for:1102 schema:inDefinedTermSet anzsrc-for:
217 schema:name Cardiorespiratory Medicine and Haematology
218 rdf:type schema:DefinedTerm
219 sg:journal.1297400 schema:issn 1468-6708
220 1745-6215
221 schema:name Trials
222 schema:publisher Springer Nature
223 rdf:type schema:Periodical
224 sg:person.01067067131.20 schema:affiliation grid-institutes:grid.275559.9
225 schema:familyName Ingwersen
226 schema:givenName Maja
227 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01067067131.20
228 rdf:type schema:Person
229 sg:person.01121532415.50 schema:affiliation grid-institutes:grid.275559.9
230 schema:familyName Lehmann
231 schema:givenName Thomas
232 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01121532415.50
233 rdf:type schema:Person
234 sg:person.012273723215.03 schema:affiliation grid-institutes:grid.275559.9
235 schema:familyName Platzer
236 schema:givenName Stephanie
237 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012273723215.03
238 rdf:type schema:Person
239 sg:person.01230314120.98 schema:affiliation grid-institutes:grid.411339.d
240 schema:familyName Scheinert
241 schema:givenName Dierk
242 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01230314120.98
243 rdf:type schema:Person
244 sg:person.01306206724.74 schema:affiliation grid-institutes:grid.418466.9
245 schema:familyName Zeller
246 schema:givenName Thomas
247 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01306206724.74
248 rdf:type schema:Person
249 sg:person.0601002133.56 schema:affiliation grid-institutes:grid.275559.9
250 schema:familyName Teichgräber
251 schema:givenName Ulf
252 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0601002133.56
253 rdf:type schema:Person
254 sg:person.0736200777.98 schema:affiliation grid-institutes:grid.275559.9
255 schema:familyName Aschenbach
256 schema:givenName René
257 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0736200777.98
258 rdf:type schema:Person
259 sg:pub.10.1007/s00270-019-02194-w schema:sameAs https://app.dimensions.ai/details/publication/pub.1112585900
260 https://doi.org/10.1007/s00270-019-02194-w
261 rdf:type schema:CreativeWork
262 grid-institutes:grid.275559.9 schema:alternateName Center for Clinical Studies, Jena University Hospital, Friedrich-Schiller-University Jena, Jena, Germany
263 Department of Radiology, Jena University Hospital, Friedrich-Schiller-University Jena, Jena, Germany
264 schema:name Center for Clinical Studies, Jena University Hospital, Friedrich-Schiller-University Jena, Jena, Germany
265 Department of Radiology, Jena University Hospital, Friedrich-Schiller-University Jena, Jena, Germany
266 rdf:type schema:Organization
267 grid-institutes:grid.411339.d schema:alternateName Department of Angiology, University Hospital Leipzig, Leipzig, Germany
268 schema:name Department of Angiology, University Hospital Leipzig, Leipzig, Germany
269 rdf:type schema:Organization
270 grid-institutes:grid.418466.9 schema:alternateName Department of Angiology, Universitäts-Herzzentrum Freiburg-Bad Krozingen, Bad Krozingen, Germany
271 schema:name Department of Angiology, Universitäts-Herzzentrum Freiburg-Bad Krozingen, Bad Krozingen, Germany
272 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...